In his past year volunteering at Neuroscape, one experience consistently comes to mind for Griffin Kreit: “At the end of every work day, without fail, I'm always thanked for the work that I do. It makes me feel appreciated.”
This gratitude drives Kreit to value his time even more in contributing to the Center’s research in psychedelics. Having just completed a post-baccalaureate program at the University of California Berkeley, Kreit has long been drawn to treatment potential of psychedelics. At Neuroscape, he is able to work with a variety of study populations, from veterans struggling with PTSD to terminal cancer patients.
“Psychedelic research is still highly stigmatized in academia, and there are very few institutions that have clearance to work with these compounds, let alone in clinical populations,” Kreit explains. “I genuinely believe in their healing potential and it's invigorating to hear the overwhelmingly positive participant feedback from so many different populations.”
|